Clinical trial
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
NCT00003426 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003426 |
|---|---|
| Title | Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer |
| Official title | A Phase I Trial of Combined Modality Gemcitabine Plus Radiation Therapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | gemcitabine hydrochloride, radiation therapy |
| Start date | Apr 1, 1998 |
| Primary completion | Mar 1, 2002 |
| Completion | Mar 1, 2002 |
| First posted | Dec 2, 2003 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: